HEADER BIOSYNTHETIC PROTEIN 21-SEP-23 8WGI TITLE MULTICYCLIC PEPTIDE MOLECULES TARGETING ROR1 WITH HIGH AFFINITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: R1-2; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: PHAGE #D; SOURCE 4 ORGANISM_TAXID: 77920 KEYWDS MULTICYCLIC PEPTIDE, DISULFIDE, BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 15 AUTHOR H.T.LIU REVDAT 3 23-APR-25 8WGI 1 JRNL REVDAT 2 13-NOV-24 8WGI 1 REMARK REVDAT 1 25-SEP-24 8WGI 0 JRNL AUTH J.LI,H.LIU,S.XIAO,S.FAN,X.CHENG,C.WU JRNL TITL DE NOVO DISCOVERY OF CYSTEINE FRAMEWORKS FOR DEVELOPING JRNL TITL 2 MULTICYCLIC PEPTIDE LIBRARIES FOR LIGAND DISCOVERY. JRNL REF J.AM.CHEM.SOC. V. 145 28264 2023 JRNL REFN ESSN 1520-5126 JRNL PMID 38092662 JRNL DOI 10.1021/JACS.3C11856 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : SHIHUI FAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8WGI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1300041242. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM R1-2, ACETONE REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-1H COSY; 2D 1H-13C HSQC; REMARK 210 2D 1H-15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 850 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA2ALPHA, NMRFAM-SPARKY, REMARK 210 NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 150 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 15 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 9 47.27 -147.46 REMARK 500 1 PRO A 11 -6.98 -57.50 REMARK 500 1 CYS A 23 60.14 -156.19 REMARK 500 2 PHE A 9 47.28 -145.38 REMARK 500 3 PHE A 9 48.22 -148.47 REMARK 500 3 CYS A 23 34.37 -141.10 REMARK 500 4 PHE A 9 50.78 -147.91 REMARK 500 4 CYS A 23 24.08 -156.96 REMARK 500 5 PHE A 9 47.78 -148.00 REMARK 500 5 PRO A 11 -6.99 -59.18 REMARK 500 6 PHE A 9 48.10 -145.90 REMARK 500 6 PRO A 11 -6.17 -58.61 REMARK 500 7 PHE A 9 48.62 -147.91 REMARK 500 7 LEU A 16 -178.44 -69.27 REMARK 500 8 PHE A 9 48.76 -147.93 REMARK 500 9 PHE A 9 49.08 -147.13 REMARK 500 10 PHE A 9 47.24 -146.36 REMARK 500 10 LEU A 16 -178.97 -69.35 REMARK 500 11 PHE A 9 48.34 -148.17 REMARK 500 12 PHE A 9 47.74 -147.87 REMARK 500 13 PHE A 9 47.92 -146.20 REMARK 500 14 PHE A 9 48.21 -147.33 REMARK 500 15 PHE A 9 47.79 -149.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36596 RELATED DB: BMRB REMARK 900 MULTICYCLIC PEPTIDE MOLECULES TARGETING ROR1 WITH HIGH AFFINITY DBREF 8WGI A 1 25 PDB 8WGI 8WGI 1 25 SEQRES 1 A 25 GLY CYS PRO PRO CYS LEU ALA LEU PHE SER PRO SER CYS SEQRES 2 A 25 GLU GLU LEU SER ILE GLN GLU CYS CYS CYS GLY TRP HELIX 1 AA1 SER A 10 GLU A 14 5 5 HELIX 2 AA2 SER A 17 CYS A 22 1 6 SSBOND 1 CYS A 2 CYS A 23 1555 1555 2.03 SSBOND 2 CYS A 5 CYS A 22 1555 1555 2.03 SSBOND 3 CYS A 13 CYS A 21 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL CONECT 15 308 CONECT 53 298 CONECT 167 288 CONECT 288 167 CONECT 298 53 CONECT 308 15 MASTER 113 0 0 2 0 0 0 6 182 1 6 2 END